Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
2823226
Reference Type
Journal Article
Title
Cancer in patients treated with coal tar: a long-term follow up study
Author(s)
Jemec, GBE; Østerlind, A
Year
1994
Is Peer Reviewed?
Yes
Journal
Journal of the European Academy of Dermatology and Venereology
ISSN:
0926-9959
EISSN:
1468-3083
Volume
3
Issue
2
Page Numbers
153-156
DOI
10.1111/j.1468-3083.1994.tb00090.x
URL
http://doi.wiley.com/10.1111/j.1468-3083.1994.tb00090.x
Exit
Abstract
Background: Coal tar is often used in dermatological therapy, although it is a recognized tumour initiator. Previous studies with observation periods of up to 25 years have not shown any increased risk of cancer in these patients, but no longer term follow up is available although the induction period for cancer is not known.
Objective: To evaluate the relative risk of cancer in a group of patients who had been treated extensively with coal tar in the period 1917–1937.
Method: The medical records of 117 patients treated extensively with coal tar from 1917 to 1937 were examined. Of these, a cohort of 88 patients (75%) were eligible for study. Cancers were identified through the Danish Cancer Registry, and relative risk of cancer in this cohort was calculated.
Results: The overall relative risk of cancer for the treated patients was found to he 0.4 (0.2–0.8).
Conclusion No overall increased risk of cancer was apparent in this group compared to that of the general population. These data provide further support of the safety of coal tar in the management of dermatological disease.
Tags
IRIS
•
Benzo(a)pyrene (BaP)
Considered
Cited
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity